文献速递前列腺癌

局部麻醉经会阴前列腺穿刺活检的多中心前瞻性结局分析

Local anaesthetic transperineal (LATP) prostate biopsy using a probe-mounted transperineal access system: a multicentre prospective outcome analysis.
PubMed 文献 · BJU Int · 2021-04-12

这项多中心前瞻性观察研究评估了使用探头固定式经会阴穿刺装置进行局部麻醉经会阴前列腺活检的可行性,纳入1218例患者,结果显示前列腺癌检出率为67%,脓毒症发生率仅0.16%,患者耐受性良好。

要点

  • 局部麻醉经会阴前列腺活检使用探头固定装置可行,前列腺癌检出率高。
  • 脓毒症发生率极低(0.16%),尿潴留发生率1.6%。
  • 多数患者(64%)报告穿刺时无痛或轻微疼痛,81%认为该操作在局麻下可耐受。

核心结论

  • 使用超声探头固定式经会阴穿刺装置进行局部麻醉经会阴前列腺活检,前列腺癌检出率优秀,脓毒症发生率极低,安全且耐受性良好。

研究设计与样本

  • 多中心前瞻性队列观察性研究,纳入连续病例,共1218例患者在英国10个中心接受局部麻醉经会阴前列腺活检。
  • 操作包括三种场景:疑似前列腺癌的首次活检、主动监测的确认活检、疑似前列腺癌的重复活检。
  • 所有患者按当地医院指南接受术前抗生素,局部麻醉采用会阴皮肤浸润和前列腺周围神经阻滞,无镇静。
  • 遵循Ginsburg协议原则进行系统活检,必要时使用PrecisionPoint™经会阴穿刺装置进行认知融合MRI靶向活检。
  • 在部分中心使用经验证的问卷收集患者报告结局指标(PROMs),共发放419份,应答率56%(n=234)。

主要发现

  • 1218例患者中,三种活检场景分别占55%、24%和21%。
  • 任何级别前列腺癌诊断816例(67%),其中临床显著疾病634例(占总数的52%)。
  • 记录到2例脓毒症(0.16%),19例尿潴留(1.6%)。
  • 在234例完成PROMs的患者中,64%报告穿刺时“完全不痛”或“轻微疼痛”;血尿是最常见症状(77%)。
  • 关于再次活检的态度,48%认为“没问题”,8.1%认为“大问题”;81%将活检描述为“局部麻醉下可耐受的轻微或中等操作”,5.6%认为需要全身麻醉。

临床怎么用

  • 局部麻醉经会阴前列腺活检使用探头固定式穿刺装置可作为经直肠超声引导活检的替代方案,脓毒症风险低且耐受性好。
  • 研究结果支持开展随机对照试验比较局部麻醉经会阴活检与经直肠超声引导活检的优劣。

局限性

  • 本研究为观察性研究,非随机对照,可能存在选择偏倚。
  • PROMs仅在部分中心收集,且应答率为56%,可能存在无应答偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the feasibility of local anaesthetic transperineal (LATP) technique using a single-freehand transperineal (TP) access device, and report initial prostate cancer (PCa) detection, infection rates, and tolerability. PATIENTS AND METHODS: Observational study of a multicentre prospective cohort, including all consecutive cases. LATP was performed in three settings: (i) first biopsy in suspected PCa, (ii) confirmatory biopsies for active surveillance, and (iii) repeat biopsy in suspected PCa. All patients received pre-procedure antibiotics according to local hospital guidelines. Local anaesthesia was achieved by perineal skin infiltration and periprostatic nerve block without sedation. Ginsburg protocol principles were followed for systematic biopsies including cognitive magnetic resonance imaging-targeted biopsies when needed using the PrecisionPoint™ TP access device. Procedure-related complications and oncological outcomes were prospectively and consecutively collected. A validated questionnaire was used in a subset of centres to collect data on patient-reported outcome measures (PROMs). RESULTS: Some 1218 patients underwent LATP biopsies at 10 centres: 55%, 24%, and 21% for each of the three settings, respectively. Any grade PCa was diagnosed in 816 patients (67%), of which 634 (52% of total) had clinically significant disease. Two cases of sepsis were documented (0.16%) and urinary retention was observed in 19 patients (1.6%). PROMs were distributed to 419 patients, with a 56% response rate (n = 234). In these men, pain during the biopsy was described as either 'not at all' or 'a little' painful by 64% of patients. Haematuria was the most common reported symptom (77%). When exploring attitude to re-biopsy, 48% said it would be 'not a problem' and in contrast 8.1% would consider it a 'major problem'. Most of the patients (81%) described the biopsy as a 'minor or moderate procedure tolerable under local anaesthesia', while 5.6% perceived it as a 'major procedure that requires general anaesthesia'. CONCLUSION: Our data suggest that LATP biopsy using a TP access system mounted to the ultrasound probe achieves excellent PCa detection, with a very low sepsis rate, and is safe and well tolerated. We believe a randomised controlled trial comparing LATP with transrectal ultrasound-guided biopsy (TRUS) to investigate the relative trade-offs between each biopsy technique would be helpful.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Lopez JF, Campbell A, Omer A, et al. Local anaesthetic transperineal (LATP) prostate biopsy using a probe-mounted transperineal access system: a multicentre prospective outcome analysis. BJU Int. 2021. PMID: 33448607. doi:10.1111/bju.15337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。